6.93
price up icon3.90%   0.26
pre-market  Pre-market:  6.81   -0.12   -1.73%
loading

Valneva Se Adr Stock (VALN) Latest News

pulisher
Feb 06, 2025

Déclaration d'actions et de droits de vote de la société Valneva SE - GlobeNewswire Inc.

Feb 06, 2025
pulisher
Jan 21, 2025

Favorable VLA1553-321 Phase 3 Study Results Boost VALN Stock - Yahoo Finance

Jan 21, 2025
pulisher
Jan 20, 2025

Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine - GlobeNewswire Inc.

Jan 20, 2025
pulisher
Dec 05, 2024

VALNEVA - GlobeNewswire Inc.

Dec 05, 2024
pulisher
Nov 28, 2024

Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock - Yahoo Finance

Nov 28, 2024
pulisher
Nov 08, 2024

Valneva SE earnings missed by $0.02, revenue fell short of estimates - Investing.com

Nov 08, 2024
pulisher
Nov 06, 2024

Valneva SE (VALN) Q3 2024 Earnings Report Preview: What to Look For - Yahoo Finance

Nov 06, 2024
pulisher
Oct 12, 2024

H.C. Wainwright maintains Buy rating on Valneva SE stock, lowers price target By Investing.com - Investing.com South Africa

Oct 12, 2024
pulisher
Oct 11, 2024

H.C. Wainwright maintains Buy rating on Valneva SE stock, lowers price target - Investing.com

Oct 11, 2024
pulisher
Oct 04, 2024

Valneva SE Declaration of shares and voting rights - GlobeNewswire Inc.

Oct 04, 2024
pulisher
Sep 25, 2024

H.C. Wainwright updates Valneva SE outlook following capital raise, reiterates Buy - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

H.C. Wainwright updates Valneva SE outlook following capital raise, reiterates Buy By Investing.com - Investing.com South Africa

Sep 25, 2024
pulisher
Sep 25, 2024

In-Depth Examination Of 6 Analyst Recommendations For Valneva - Benzinga

Sep 25, 2024
pulisher
Sep 04, 2024

Valneva shares hold strong with buy rating on Lyme vaccine data - Investing.com

Sep 04, 2024
pulisher
Sep 04, 2024

Wall Street Analysts Predict a 150.41% Upside in Valneva (VALN): Here's What You Should Know - MSN

Sep 04, 2024
pulisher
Sep 03, 2024

Favorable VLA15 Phase 2 Study Results Might Boost VALN Stock - Zacks Investment Research

Sep 03, 2024
pulisher
Aug 15, 2024

How Much Upside is Left in Valneva (VALN)? Wall Street Analysts Think 135.3% - Yahoo Finance

Aug 15, 2024
pulisher
Jul 26, 2024

Can Valneva (VALN) Climb 149.04% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance

Jul 26, 2024
pulisher
Jul 08, 2024

Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine - Zacks Investment Research

Jul 08, 2024
pulisher
Mar 21, 2024

Earnings call: Valneva reports robust growth and strategic R&D focus By Investing.com - Investing.com South Africa

Mar 21, 2024
pulisher
May 30, 2023

Valneva (VALN) Stock Down 53% in the Past Year: Here's Why - Nasdaq

May 30, 2023
pulisher
Jan 16, 2023

Valneva (VALN) Stock Down 61.5% in the Past Year: Here's Why - Yahoo Finance

Jan 16, 2023
pulisher
Jun 14, 2022

Valneva (VALN) Down on its COVID-19 Vaccine Update in Europe - Zacks Investment Research

Jun 14, 2022
pulisher
May 17, 2022

Valneva (VALN) Down as EU Considers Ending COVID-Vaccine Deal - Yahoo Finance

May 17, 2022
pulisher
Apr 03, 2022

5 Top Health Care Stocks To Watch In The Stock Market Today - Stock Market

Apr 03, 2022
pulisher
Nov 24, 2021

Valneva Stock Is Jumping on European Vaccine Supply Deal - Barron's

Nov 24, 2021
pulisher
Nov 10, 2021

Valneva Stock Surges After EU Vaccine Deal - Investing.com

Nov 10, 2021
pulisher
Oct 27, 2021

Valneva Shares Off 12% On Share Offering News By Investing.com - Investing.com UK

Oct 27, 2021
pulisher
Oct 19, 2021

Valneva (VALN) Reports Positive Data From COVID Vaccine Study - Nasdaq

Oct 19, 2021
pulisher
Sep 13, 2021

Valneva Stock Plunges as U.K. Drops Covid-19 Vaccine Deal - Barron's

Sep 13, 2021
pulisher
May 07, 2021

EU set to sign off new Pfizer vaccine contract as soon as Friday - Luxembourg Times

May 07, 2021
pulisher
Jul 08, 2019

Shareholder Structure - Valneva

Jul 08, 2019
pulisher
Jul 08, 2019

Stock Price - Valneva

Jul 08, 2019
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):